George Rieveschl, Inventor of Benadryl, Dies
CINCINNATIUniversity of Cincinnati (UC) alumnus and engineering professor emeritus George Rieveschl, PhD, known for inventing Benadryl, the worlds first effective antihistamine, died today at Christ Hospital, Cincinnati. He was 91.
A long-time supporter of the
Dr. Rieveschl was also the founding chairman of the University Foundation Board of Trustees.
Rieveschl was a chemistry professor at UC when he invented Benadryl.
He found to this surprise that a two-part compound he was originally testing to improve muscle-relaxing medications dramatically blocked histamine, the naturally released chemical that narrows air passages in the lungs and causes inflammation.
This breakthrough led, in 1946, to Benadryls becoming the first FDA-approved prescription antihistamine. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970.
He is survived by his wife, Ellen, and two sons.
George Rieveschl, PhD
Jane Henney, MD, presents Benadryl inventor George Rieveschl, PhD, with a city proclamation noting May 16 as "60 Years of Benadryl" day.
Related Stories
'My health is priceless'
April 7, 2026
Weight loss drugs, including Ozempic and Wegovy, are changing more than waistlines — they're quietly transforming how people spend money, what they prioritize and who can afford better health. As Local 12/WKRC-TV recently reported, for some patients, the medications are life-changing. For others, the cost can be overwhelming.
Students prefer AI chatbots, until they know it is one
April 7, 2026
A University of Cincinnati College of Nursing pilot study found that Doctor of Nursing Practice students preferred AI chatbot responses over human answers — until they suspected the source was a chatbot, revealing trust issues in higher education advising.
What is the 'cicada' COVID variant?
April 6, 2026
A formerly rare strain of COVID, BA.3.2, now is showing up in Ohio and 24 other states. Experts say so far it hasn't caused illness any more severe than other strains, but it might be somewhat more resistant to vaccines, as 91.7 WVXU News recently reported. Scientists have nicknamed the variant "cicada" due to its former low profile and current resurgence.